Pertussis toxin reduces the number of splenic Foxp3+ regulatory T cells

Journal of Immunology

Volumn 177, Issue 3, 2006, Pages 1552-1560

  Cassan, Cécile ^a   Piaggio, Eliane ^a   Zappulla, Jacques P ^a   Mars, Lennart T ^a   Couturier, Nicolas ^a   Bucciarelli, Florence ^a   Desbois, Sabine ^a   Bauer, Jan ^b   Gonzalez Dunia, Daniel ^a   Liblau, Roland S ^a,c  

^a INSERM   (France)

^b UNIVERSITY OF VIENNA   (Austria)

^c CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS TOXIN; TRANSCRIPTION FACTOR FOXP3;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BLOOD BRAIN BARRIER; CD4+ CD25+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; LIVER; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION;

EID: 33746214834     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.3.1552     Document Type: Article

References (73)

1. Munoz, J. J., C. C. Bernard, and I. R. Mackay. 1984. Elicitation of experimental allergic encephalomyelitis (EAE) in mice with the aid of pertussigen. Cell. Immunol. 83: 92-100.
2. Linthicum, D. S. 1982. Development of acute autoimmune encephalomyelitis in mice: factors regulating the effector phase of the disease. Immunobiology 162: 211-220.
3. Kohno, S., J. A. Munoz, T. M. Williams, C. Teuscher, C. C. Bernard, and K. S. Tung. 1983. Immunopathology of murine experimental allergic orchitis. J. Immunol. 130: 2675-2682.
4. Hou, W., Y. Wu, S. Sun, M. Shi, Y. Sun, C. Yang, G. Pei, Y. Gu, C. Zhong, and B. Sun. 2003. Pertussis toxin enhances Th1 responses by stimulation of dendritic cells. J. Immunol. 170: 1728-1736.
5. Agarwal, R. K., S. H. Sun, S. B. Su, C. C. Chan, and R. R. Caspi. 2002. Pertussis toxin alters the innate and the adaptive immune responses in a pertussis-dependent model of autoimmunity. J. Neuroimmunol. 129: 133-140.
6. Hart, M. N., D. S. Linthicum, M. M. Waldschmidt, S. K. Tassell, R. L. Schelper, and R. A. Robinson. 1987. Experimental autoimmune inflammatory myopathy. J. Neuropathol. Exp. Neurol. 46: 511-521.
7. Nencioni, L., M. G. Pizza, G. Volpini, M. T. De Magistris, F. Giovannoni, and R. Rappuoli. 1991. Properties of the B oligomer of pertussis toxin. Infect. Immun. 59: 4732-4734.
8. Mascart, F., V. Verscheure, A. Malfroot, M. Hainaut, D. Pierard, S. Temerman, A. Peltier, A. S. Debrie, J. Levy, G. Del Giudice, and C. Locht. 2003. Bordetella pertussis infection in 2-month-old infants promotes type 1 T cell responses. J. Immunol. 170: 1504-1509.
9. Tonon, S., S. Goriely, E. Aksoy, O. Pradier, G. Del Giudice, E. Trannoy, F. Willems, M. Goldman, and D. De Wit. 2002. Bordetella pertussis toxin induces the release of inflammatory cytokines and dendritic cell activation in whole blood: impaired responses in human newborns. Eur. J. Immunol. 32: 3118-3125.
10. Nicosia, A., M. Perugini, C. Franzini, M. C. Casagli, M. G. Borri, G. Antoni, M. Almoni, P. Neri, G. Ratti, and R. Rappuoli. 1986. Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplication. Proc. Natl. Acad. Sci. USA 83: 4631-4635.
11. Brennan, M. J., J. L. David, J. G. Kenimer, and C. R. Manclark. 1988. Lectin-like binding of pertussis toxin to a 165-kilodalton Chinese hamster ovary cell glycoprotein. J. Biol. Chem. 263: 4895-4899.
12. Tuomanen, E., H. Towbin, G. Rosenfelder, D. Braun, G. Larson, G. C. Hansson, and R. Hill. 1988. Receptor analogs and monoclonal antibodies that inhibit adherence of Bordetella pertussis to human ciliated respiratory epithelial cells. J. Exp. Med. 168: 267-277.
13. Witvliet, M. H., D. L. Burns, M. J. Brennan, J. T. Poolman, and C. R. Manclark. 1989. Binding of pertussis toxin to eucaryotic cells and glycoproteins. Infect. Immun. 57: 3324-3330.
14. Katada, T., T. Amano, and M. Ui. 1982. Modulation by islet-activating protein of adenylate cyclase activity in C6 glioma cells. J. Biol. Chem. 257: 3739-3746.
15. Katada, T., and M. Ui. 1982. Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein. Proc. Natl. Acad. Sci. USA 79: 3129-3133.
16. Mielċarek, N., E. H. Hornquist, B. R. Johansson, C. Locht, S. N. Abraham, and J. Holmgren. 2001. Interaction of Bordetella pertussis with mast cells, modulation of cytokine secretion by pertussis toxin. Cell Microbiol. 3: 181-188.
17. Darabi, K., A. Y. Karulin, B. O. Boehm, H. H. Hofstetter, Z. Fabry, J. C. LaManna, J. C. Chavez, M. Tary-Lehmann, and P. V. Lehmann. 2004. The third signal in T cell-mediated autoimmune disease? J. Immunol. 173: 92-99.
18. He, J., S. Gurunathan, A. Iwasaki, B. Ash-Shaheed, and B. L. Kelsall. 2000. Primary role for Gi protein signaling in the regulation of interleukin 12 production and the induction of T helper cell type 1 responses. J. Exp. Med. 191: 1605-1610.
19. Ryan, M., L. McCarthy, R. Rappuoli, B. P. Mahon, and K. H. Mills. 1998. Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28. Int. Immunol. 10: 651-662.
20. Shive, C. L., H. Hofstetter, L. Arredondo, C. Shaw, and T. G. Forsthuber. 2000. The enhanced antigen-specific production of cytokines induced by pertussis toxin is due to clonal expansion of T cells and not to altered effector functions of long-term memory cells. Eur. J. Immunol. 30: 2422-2431.
21. Hofstetter, H. H., C. L. Shive, and T. G. Forsthuber. 2002. Pertussis toxin modulates the immune response to neuroantigens injected in incomplete Freund's adjuvant: induction of ThI cells and experimental autoimmune encephalomyelitis in the presence of high frequencies of Th2 cells. J. Immunol. 169: 117-125.
22. Cyster, J. G., and C. C. Goodnow. 1995. Pertussis toxin inhibits migration of B and T lymphocytes into splenic white pulp cords. J. Exp. Med. 182: 581-586.
23. Alt, C., M. Laschinger, and B. Engelhardt. 2002. Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis. Eur. J. Immunol. 32: 2133-2144.
24. Linthicum, D. S., J. J. Munoz, and A. Blaskett. 1982. Acute experimental autoimmune encephalomyelitis in mice. 1. Adjuvant action of Bordetella pertussis is due to vasoactive amine sensitization and increased vascular permeability of the central nervous system. Cell. Immunol. 73: 299-310.
25. Linthicum, D. S., and J. A. Frelinger. 1982. Acute autoimmune encephalomyelitis in mice. II. Susceptibility is controlled by the combination of H-2 and histamine sensitization genes. J. Exp. Med. 156: 31-40.
26. Bruckener, K. E., A. el Baya, H. J. Galla, and M. A. Schmidt. 2003. Permeabilization in a cerebral endothelial barrier model by pertussis toxin involves the PKC effector pathway and is abolished by elevated levels of cAMP. J. Cell Sci. 116: 1837-1846.
27. Kerfoot, S. M., E. M. Long, M. J. Hickey, G. Andonegui, B. M. Lapointe, R. C. Zanardo, C. Bonder, W. G. James, S. M. Robbins, and P. Kubes. 2004. TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease. J. Immunol. 173: 7070-7077.
28. Racke, M. K., W. Hu, and A. E. Lovett-Racke. 2005. PTX cruiser: driving autoimmunity via TLR4. Trends Immunol. 26: 289-291.
29. Kamradt, T., P. D. Soloway, D. L. Perkins, and M. L. Gefter. 1991. Pertussis toxin prevents the induction of peripheral T cell anergy and enhances the T cell response to an encephalitogenic peptide of myelin basic protein. J. Immunol. 147: 3296-3302.
30. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22:531-562.
31. Fontenot, J. D., J. P. Rasmussen, L. M. Williams, J. L. Dooley, A. G. Farr, and A. Y. Rudensky. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 22: 329-341.
32. + T cells that prevent spontaneous autoimmune encephalomyelitis. J. Immunol. 164: 5499-5507.
33. + regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169: 4712-4716.
34. + regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc. Natl. Acad. Sci. USA 99: 8213-8218.
35. + regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 101: 15434-15439.
36. + regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199: 971-979.
37. high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur. J. Immunol. 35: 3343-3352.
38. Wakatsuki, A., P. Borrow, K. Rigley, and P. C. Beverley. 2003. Cell-surface bound pertussis toxin induces polyclonal T cell responses with high levels of interferon-γ in the absence of interleukin-12. Eur. J. Immunol. 33: 1859-1868.
39. + T cells: a highly differentiated and apoptosis-prone population. Eur. J. Immunol. 31: 1122-1131.
40. + T cells: analysis using depleting antibodies. J. Autoimmun. 23: 1-7.
41. + regulatory T cells limit the risk of autoimmune disease arising from T cell receptor crossreactivity. Proc. Natl. Acad. Sci. USA 102: 17418-17423.
42. Banz, A., C. Pontoux, and M. Papiernik. 2002. Modulation of Fas-dependent apoptosis: a dynamic process controlling both the persistence and death of CD4 regulatory T cells and effector T cells. J. Immunol. 169: 750-757.
43. - T cells to dexamethasone-induced cell death. Eur. J. Immunol. 34: 859-869.
44. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886.
45. + T-cell pool and the expression of Foxp3 in vivo. Int. Immunol. 16: 1241-1249.
46. + T cells. J. Immunol. 173: 6526-6531.
47. + regulatory T cells. J. Exp. Med. 201: 1061-1067.
48. -/- mice. J. Immunol. 174: 6122-6128.
49. + regulatory T cells in the absence of interleukin 2 signaling. Nat. Immunol. 6: 1152-1159.
50. Fontenot, J. D., J. P. Rasmussen, M. A. Gavin, and A. Y. Rudensky. 2005. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6: 1142-1151.
51. Evans, S. W., S. K. Beckner, and W. L. Farrar. 1987. Stimulation of specific GTP binding and hydrolysis activities in lymphocyte membrane by interleukin-2. Nature 325: 166-168.
52. Crispe, I. N. 2003. Hepatic T cells and liver tolerance. Nat. Rev. Immunol. 3: 51-62.
53. + T cells. J. Immunol. 172: 890-898.
54. + T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J. Exp. Med. 201: 1037-1044.
55. + regulatory T cells during acute graft-versus-host disease. Blood 106: 3300-3307.
56. + T-cell subset. Blood 105: 2877-2886.
57. + splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 169: 2461-2465.
58. Su, S. B., P. B. Silver, M. Zhang, C. C. Chan, and R. R. Caspi. 2001. Pertussis toxin inhibits induction of tissue-specific autoimmune disease by disrupting G protein-coupled signals. J. Immunol. 167: 250-256.
59. Vlahakis, S. R., A. Villasis-Keever, T. Gomez, M. Vanegas, N. Vlahakis, and C. V. Paya. 2002. G protein-coupled chemokine receptors induce both survival and apoptotic signaling pathways. J. Immunol. 169: 5546-5554.
60. Rot, A., and U. H. von Andrian. 2004. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 22: 891-928.
61. Rosen, H., and E. J. Goetzl. 2005. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat. Rev. Immunol. 5: 560-570.
62. + T regulatory cells and enhances their functional activity. J. Immunol. 175: 7973-7980.
63. - CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion. Proc. Natl. Acad Sci. USA 102: 4091-4096.
64. Brabb, T., A. W. Goldrath, P. von Dassow, A. Paez, H. D. Liggitt, and J. Goverman. 1997. Triggers of autoimmune disease in a murine TCR-transgenic model for multiple sclerosis. J. Immunol. 159: 497-507.
65. Billiau, A., and P. Matthys. 2001. Modes of action of Freund's adjuvants in experimental models of autoimmune diseases. J. Leukocyte Biol. 70: 849-860.
66. Waldner, H., M. Collins, and V. K. Kuchroo. 2004. Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease. J. Clin. Invest. 113: 990-997.
67. Visser, L., H. Jan de Heer, L. A. Boven, D. van Riel, M. van Meurs, M. J. Melief, U. Zahringer, J. van Strijp, B. N. Lambrecht, E. E. Nieuwenhuis, and J. D. Laman. 2005. Proinflammatory bacterial peptidoglycan as a cofactor for the development of central nervous system autoimmune disease. J. Immunol. 174: 808-816.
68. Caramalho, I., T. Lopes-Carvalho, D. Ostler, S. Zelenay, M. Haury, and J. Demengeot. 2003. Regulatory T cells selectively express Toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 197: 403-411.
69. + regulatory T cell function. Science 309: 1380-1384.
70. + T cell-mediated suppression by dendritic cells. Science 299: 1033-1036.
71. Kubo, T., R. D. Hatton, J. Oliver, X. Liu, C. O. Elson, and C. T. Weaver. 2004. Regulatory T cell suppression and anergy are differentially regulated by proinflammatory cytokines produced by TLR-activated dendritic cells. J. Immunol. 173: 7249-7258.
72. Buljevac, D., H. Z. Flach, W. C. Hop, D. Hijdra, J. D. Laman, H. F. Savelkoul, F. G. van Der Meche, P. A. van Doom, and R. Q. Hintzen. 2002. Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain 125: 952-960.
73. + T regulatory cells. Eur. J. Immunol. 36: 671-680.